Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Josef Endl"'
Autor:
Stefan Seeber, Francesca Ros, Irmgard Thorey, Georg Tiefenthaler, Klaus Kaluza, Valeria Lifke, Jens André Alexander Fischer, Stefan Klostermann, Josef Endl, Erhard Kopetzki, Achal Pashine, Basile Siewe, Brigitte Kaluza, Josef Platzer, Sonja Offner
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e86184 (2014)
We have developed a robust platform to generate and functionally characterize rabbit-derived antibodies using B cells from peripheral blood. The rapid high throughput procedure generates a diverse set of antibodies, yet requires only few animals to b
Externí odkaz:
https://doaj.org/article/121e8ae00e8c4eaa9913c08d88a77bdd
Supplementary Figure 2 from Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f655ef5403f9e7b115f698cd7ea72d9
https://doi.org/10.1158/0008-5472.22380909.v1
https://doi.org/10.1158/0008-5472.22380909.v1
The human epidermal growth factor receptor (HER) family plays an important role in cell survival and proliferation, and is implicated in oncogenesis. Overexpression of HER2 is associated with aggressive disease and poor prognosis. Trastuzumab is a hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9e0fa3c88b9605f647097f0aa7f938d
https://doi.org/10.1158/0008-5472.c.6499707.v1
https://doi.org/10.1158/0008-5472.c.6499707.v1
Supplementary Figure 1 from Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::399a612cc6315fe8a753285c829d6182
https://doi.org/10.1158/0008-5472.22380912.v1
https://doi.org/10.1158/0008-5472.22380912.v1
Supplementary Figure Legends 1-2 from Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::800eaf0077b9d131d84089c875efbec3
https://doi.org/10.1158/0008-5472.22380906
https://doi.org/10.1158/0008-5472.22380906
Autor:
Lassané Ouedraogo, Martin Kiendrebeogo, Pierre Alexandre Eric Djiffaby Sombié, Josef Endl, Hanno Schaefer
Publikováno v:
Ethnobotany Research and Applications. 20
Background: A comprehensive survey on the trade and use of medicinal plants in Burkina Faso was carried out with the aim of identifying the most relevant species and their conservation status. Methods: Interviews of 30 medicinal plant traders in six
Autor:
Arun K. Pandey, Belén Picó, Enoch G. Achigan-Dako, Antonio J. Monforte, Hanno Schaefer, Josef Endl
Publikováno v:
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
instname
Premise of the study The domestication history of melon is still unclear. An African or Asian origin has been suggested, but its closest wild relative was recently revealed to be an Australian species. The complicated taxonomic history of melon has r
Publikováno v:
Cancer Research. 69:9330-9336
The human epidermal growth factor receptor (HER) family plays an important role in cell survival and proliferation, and is implicated in oncogenesis. Overexpression of HER2 is associated with aggressive disease and poor prognosis. Trastuzumab is a hu
Autor:
Josef Endl, James A. Dromey, Sarah M. Weenink, Michael R. Christie, Ian Todd, Patrick J. Tighe, Günther H.J. Peters
Publikováno v:
ResearcherID
IA-2 is a major target of autoimmunity in type 1 diabetes. IA-2 responsive T cells recognize determinants within regions represented by amino acids 787–817 and 841–869 of the molecule. Epitopes for IA-2 autoantibodies are largely conformational a
Autor:
N. Duhindan, J. Orgiazzi, Josef Endl, Anne-Marie Madec, P van Endert, J. P. Banga, J. K. Moore
Publikováno v:
Clinical and Experimental Immunology. 135:74-84
SUMMARY We used a GAD65-specific human B–T cell line cognate system in vitro to investigate the modulation of GAD65 presentation by autoantibody, assessed in a proliferation assay. Generally, if the T cell determinant overlaps or resides within the